UA47047A - Спосіб лікування хворих на правець - Google Patents
Спосіб лікування хворих на правець Download PDFInfo
- Publication number
- UA47047A UA47047A UA2001074577A UA200174577A UA47047A UA 47047 A UA47047 A UA 47047A UA 2001074577 A UA2001074577 A UA 2001074577A UA 200174577 A UA200174577 A UA 200174577A UA 47047 A UA47047 A UA 47047A
- Authority
- UA
- Ukraine
- Prior art keywords
- tetanus
- antitoxin
- patients
- treatment
- purified
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 6
- 230000001147 anti-toxic effect Effects 0.000 claims abstract description 13
- 206010043376 Tetanus Diseases 0.000 claims abstract description 12
- 239000003547 immunosorbent Substances 0.000 claims abstract description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 238000012876 topography Methods 0.000 claims 1
- 229960005367 tetanus antitoxin Drugs 0.000 abstract description 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 4
- 208000007101 Muscle Cramp Diseases 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 108010055044 Tetanus Toxin Proteins 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 239000009863 chlorophyllypt Substances 0.000 description 2
- OKGXJRGLYVRVNE-UHFFFAOYSA-N diaminomethylidenethiourea Chemical compound NC(N)=NC(N)=S OKGXJRGLYVRVNE-UHFFFAOYSA-N 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 229940035363 muscle relaxants Drugs 0.000 description 2
- 239000003158 myorelaxant agent Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 229940118376 tetanus toxin Drugs 0.000 description 2
- BKUKXOMYGPYFJJ-UHFFFAOYSA-N 2-ethylsulfanyl-1h-benzimidazole;hydrobromide Chemical compound Br.C1=CC=C2NC(SCC)=NC2=C1 BKUKXOMYGPYFJJ-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Способ лечения больных столбняком заключается в интрацистернальном введении столбнячного антитоксина. Используют очищенный с помощью иммуносорбентов антитоксин, лишенный балластных белков. В дополнение к антитоксину вводят антигипоксанты.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2001074577A UA47047A (uk) | 2001-07-03 | 2001-07-03 | Спосіб лікування хворих на правець |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2001074577A UA47047A (uk) | 2001-07-03 | 2001-07-03 | Спосіб лікування хворих на правець |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA47047A true UA47047A (uk) | 2002-06-17 |
Family
ID=74221662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2001074577A UA47047A (uk) | 2001-07-03 | 2001-07-03 | Спосіб лікування хворих на правець |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA47047A (ru) |
-
2001
- 2001-07-03 UA UA2001074577A patent/UA47047A/uk unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2704454T3 (es) | Composiciones antimicrobianas que comprenden hipohalito y/o hipotiocianito y sus usos | |
| UA73115C2 (en) | Use of dipeptidyl peptidase iv inhibitors for treating short stature due to growth hormone deficiency | |
| ATE489956T1 (de) | Formulierungen enthaltend salicylate und deren verwendung zur behandlung von entzündlicher darmerkrankung | |
| ATE325633T1 (de) | Vorrichtung zur gleichzeitigen verabreichung von gasen und medikamenten | |
| MX9302160A (es) | Composiciones farmaceuticas del interferon de leu cocito humano concordante. | |
| Yoon et al. | Complete Remission of Hypereosinophilic Syndrome after Interferon‐α Therapy: Report of a Case and Literature Review | |
| Fisher et al. | Veillonella parvula bacteremia without an underlying source | |
| DE60136381D1 (de) | Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität | |
| ES2114073T3 (es) | Regeneracion del higado inducida por morfogenes. | |
| RU2150281C1 (ru) | Способ лечения респираторных болезней телят | |
| UA47047A (uk) | Спосіб лікування хворих на правець | |
| JP2011012060A (ja) | 慢性疲労症候群の治療用の医薬の製造のための、アルファ−１−アンチトリプシンの使用 | |
| ATE545423T1 (de) | Mittel zur behandlung von lungenkrebs | |
| RU2099061C1 (ru) | Способ лечения нейродермита | |
| Stone | The possible role of mega-ascorbate in the endogenous synthesis of interferon | |
| EP0747477A4 (en) | TRICHODERMA HARZIEANUM RIFAI STEM, METHOD FOR RECEIVING L-LYSINE-ALPHA-OXIDASE AS A VIRAL AND BACTERIAL ACTIVITY INHIBITOR, IMMUNOMODULATOR AND SKIN HEALING AGENT | |
| RU2246957C2 (ru) | Способ лечения хронического h.pylori-ассоциированного гастрита препаратом ламинолакт | |
| FR2745186B1 (fr) | Complexe immunomodulateur et ses utilisations pour le traitement et la prevention des recidives des affections par helicobacter | |
| RU2200579C1 (ru) | Способ профилактики и лечения респираторных болезней телят | |
| SU1629062A1 (ru) | Способ лечени колибактериоза тел т | |
| Maslov et al. | Effect of peroxidase on the development of experimental leprosy in mice after intraplantar infection | |
| Ivanova et al. | PECULIARITIES OF TREATMENT OF ACUTE RESPIRATORY DISEASES IN CHILDREN (literature review) | |
| Deycke | A lecture on a specific treatment of leprosy | |
| RU2123357C1 (ru) | Способ повышения неспецифической резистентности организма при заболеваниях нервной системы | |
| JPH0132209B2 (ru) |